You haven't searched anything yet.
Company Summary:
Ring Therapeutics Inc. is a privately held, early-stage biotechnology company pioneering a completely novel form of gene therapy by exploiting a family of naturally occurring commensal viruses to create the first redosable and targetable DNA medicines. This approach enables a powerful new class of tropic, persistent, non-integrating vectors that overcome the immunogenicity, and limited tropism of existing gene therapy vectors. Ring Therapeutics is leveraging this versatile technology to develop a broad pipeline of novel, targeted medicines for disease with high unmet medical need.
Ring Therapeutics was founded by Flagship Pioneering, focused on launching breakthrough companies based on internally conceived innovations and insights. Flagship Pioneering has created over 40 groundbreaking companies over the past fifteen years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Seres Therapeutics (NASDAQ:MCRB), Moderna, Syros Pharmaceuticals (SYRS), Rubius Therapeutics, Axcella Health, Evelo Biosciences, and Indigo Agriculture.
Position Summary:
Ring is seeking an Associate Scientist to join the Upstream Process Development team to help establish and develop our viral vector platform. The candidate will work directly with a team of scientists to implement a bioreactor/suspension-based process at the miniature and benchtop volumes with a focus on scaling to larger systems. This position will include opportunities to evaluate new cell culture technologies, generate process improvements through optimization of current unit operations, as well as early characterization of the novel platform. The candidate will lead experimental design and strategy, execution, and analysis of a variety of generated data sets. The candidate will interface with equipment companies and other vendors, research institutes/universities, and contract manufacturing organizations as required to accelerate the development effort. This will be a great opportunity to be exposed to aspects of viral biology as well as process development in a translational context. We are searching for enthusiastic and highly motivated individuals who are comfortable multitasking and working independently on various aspects of the gene therapy production platform.
Responsibilities:
Minimum Qualifications:
Full Time
Business Services
$124k-161k (estimate)
07/28/2023
05/15/2024
flagshippioneering.com
CAMBRIDGE, MA
500 - 1,000
2000
VOLKER HERRMANN
$50M - $200M
Business Services
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other insti...tutions. The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).
More
Show less